IL17A and rheumatoid arthritis: However, Kunwar et al. performed a meta-analysis of seven RCTs about rheumatoid arthritis and reported that IL-17A inhibitors did not significantly increase the risk of AEs or SAEs in rheumatoid arthritis [55].